SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001102624-16-002678
Filing Date
2016-05-04
Accepted
2016-05-04 17:29:08
Documents
3
Period of Report
2016-05-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 THERAVANCE BIOPHARMA, INC. 8-K theravancebiopharma8k.htm 8-K 15853
2 EXHIBIT 99.1 exh99_1.htm EX-99.1 4114
3 image00001.jpg GRAPHIC 10988
  Complete submission text file 0001102624-16-002678.txt   36347
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36033 | Film No.: 161620694
SIC: 2834 Pharmaceutical Preparations